On-Cycle Cardiovascular Support: Supplements Ranked by Evidence

These three supplements have consistent clinical trial data supporting their use for the specific cardiovascular changes induced by AAS.

Omega-3 Fatty Acids (3-4 g EPA+DHA per day). Omega-3s are the single most evidence-supported supplement for AAS users. At 3-4 grams of combined EPA and DHA per day, they reduce triglycerides by 20-30 percent, modestly lower ApoB (10-15 percent), and support endothelial function. A 2019 meta-analysis in the Journal of the American Heart Association found that EPA+DHA at this dose reduces cardiovascular events by approximately 15 percent in high-risk populations. For AAS users specifically, omega-3s partially counteract the triglyceride elevation caused by orals and high-dose testosterone. The key is dose: most fish oil capsules contain 300-500 mg of combined EPA+DHA, meaning you need 6-8 capsules per day. Do not rely on "standard" dosing.

Citrus Bergamot (500-1000 mg/day). Bergamot is arguably the most underrated lipid support supplement. Standardized to 500-1000 mg of polyphenolic flavonoids per day, it reduces LDL by 20-35 percent in clinical studies — comparable to low-dose statins. The mechanism involves inhibition of HMG-CoA reductase (like statins) plus antioxidant effects. A 2018 randomized trial in the International Journal of Cardiology found that bergamot reduced LDL from 155 to 118 mg/dL over six months. For AAS users who cannot or will not take statins, bergamot is a legitimate alternative.

CoQ10 (200-400 mg/day). Coenzyme Q10 serves two roles for AAS users. First, it is essential for mitochondrial function, and oral AAS are known to impair mitochondrial health in cardiac tissue. Second, it is mandatory if you take a statin, because statins deplete endogenous CoQ10 production. The ubiquinol form (reduced CoQ10) has better bioavailability. A 2022 study in the Journal of Clinical Lipidology recommended 200-400 mg/day for patients on statins to prevent statin-associated muscle symptoms.

These supplements have promising data for specific indications but are not as broadly supported as Tier 1.

Naringin (250-500 mg/day). Naringin is the flavonoid responsible for grapefruit's interaction with medications — and it happens to reduce hematocrit. A 2021 study in Clinical Hemorheology and Microcirculation found that naringin reduced hematocrit by 4-6 percent in patients with polycythemia over 12 weeks. The mechanism involves inhibition of erythropoietin signaling. For AAS users with hematocrit creeping above 52 percent, naringin may offer a natural alternative to therapeutic phlebotomy. Note: naringin interacts with many medications (statins, calcium channel blockers, benzodiazepines) by inhibiting CYP3A4 — check for interactions before use.

Garlic Extract (standardized to allicin, 600-1200 mg/day). Aged garlic extract has consistent data for modest blood pressure reduction: approximately 5-8 mmHg systolic and 2-4 mmHg diastolic, based on a 2016 meta-analysis in the Journal of Nutrition. The mechanism involves hydrogen sulfide production and nitric oxide potentiation. For AAS users with BP creeping into the 130-140 mmHg range, garlic extract is a reasonable first step before medication. It does not replace telmisartan or other antihypertensives when BP exceeds 140/90 despite lifestyle optimization.

Berberine (500 mg, 2-3 times per day). Berberine is best known for glucose management, but it also has lipid-lowering effects: 15-25 percent LDL reduction in clinical trials, comparable to a low-dose statin. The mechanism involves AMPK activation, which improves insulin sensitivity and reduces hepatic lipid synthesis. For AAS users, berberine is most useful when orals or GH have pushed fasting glucose above 100 mg/dL. The downside: gastrointestinal side effects are common, and berberine requires divided dosing (500 mg 2-3 times daily) for sustained AMPK activation.

These supplements have theoretical or preliminary support but are not first-line choices.

Vitamin E (mixed tocopherols, 400-800 IU/day). Gamma-tocopherol has shown some benefits for prolactin management, which is relevant for nandrolone and Trenbolone users who experience prolactin-related sides. However, high-dose alpha-tocopherol (> 400 IU) has been associated with increased mortality in large meta-analyses. Use mixed tocopherols at moderate doses, and prefer prolactin control through compound adjustment or P5P.

P5P (Pyridoxal-5-Phosphate, 50-100 mg/day). The active form of vitamin B6 is a cofactor in dopamine synthesis, which inhibits prolactin. For nandrolone or Trenbolone users, P5P at 50-100 mg/day can help manage prolactin elevation. The evidence is primarily mechanistic rather than clinical, but the safety profile is excellent and the cost is minimal (5-10 euros per month).

Celery Seed Extract (standardized, 300-600 mg/day). Contains phthalides that relax arterial smooth muscle, producing a modest BP reduction of 3-5 mmHg in some studies. The evidence base is thin but consistent. For users who want to try lifestyle + supplements before moving to medication, celery seed extract is a safe addition.

There is a limit to what supplements can achieve. If your ApoB is above 130 mg/dL despite optimized omega-3 and bergamot supplementation, you need medication — not more supplements. If your BP remains above 140/90 despite garlic, celery seed, and full lifestyle optimization, you need telmisartan or an ACE inhibitor.